End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
32.4 TWD | -1.07% | -1.37% | +66.58% |
Apr. 19 | 3D Global Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | 3D Global Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2022 | 13.64M 422K | Sales 2023 | 20.63M 638K | Capitalization | 1.09B 33.65M |
---|---|---|---|---|---|
Net income 2022 | -67M -2.07M | Net income 2023 | -58M -1.79M | EV / Sales 2022 | 95.7 x |
Net cash position 2022 | 192M 5.93M | Net cash position 2023 | 156M 4.81M | EV / Sales 2023 | 45.2 x |
P/E ratio 2022 |
-22
x | P/E ratio 2023 |
-18.9
x | Employees | 34 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 80.84% |
1 day | -1.07% | ||
1 week | -1.37% | ||
Current month | -4.00% | ||
1 month | +2.69% | ||
3 months | +11.72% | ||
6 months | +69.19% | ||
Current year | +66.58% |
Managers | Title | Age | Since |
---|---|---|---|
Keng Liang Ou
CEO | Chief Executive Officer | - | 15-01-14 |
Jui Wen Huang
DFI | Director of Finance/CFO | - | 17-04-17 |
Hsu An Pan
CTO | Chief Tech/Sci/R&D Officer | - | 20-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ming Hsien Chen
BRD | Director/Board Member | - | 20-11-18 |
Chi Ying Chiu
BRD | Director/Board Member | - | 20-11-18 |
Keng Liang Ou
CEO | Chief Executive Officer | - | 15-01-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 32.4 | -1.07% | 127 420 |
24-05-13 | 32.75 | +1.08% | 125,230 |
24-05-10 | 32.4 | +0.15% | 56,462 |
24-05-09 | 32.35 | +1.09% | 62,265 |
24-05-08 | 32 | -1.99% | 156,639 |
End-of-day quote Taipei Exchange, May 13, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
+66.58% | 67.48M | |
-5.94% | 182B | |
+1.63% | 111B | |
-3.73% | 68.48B | |
+0.76% | 49.69B | |
+7.75% | 44.46B | |
+2.33% | 40.67B | |
+22.51% | 31.22B | |
-0.91% | 26.09B | |
+15.30% | 25.32B |
- Stock Market
- Equities
- 6808 Stock